References:
1. Gean CJ & Meyers FH: Pocket Drug Guide, 2nd ed. Williams & Wilkins, Baltimore, MD; 1997.
2. Tyler VE: The New Honest Herbal. GF Stickley Co, Philadelphia, PA; 1987.
3. Fleming T (ed): PDR for Herbal Medicines. Medical Economics Company, Montvale, NJ; 1998.
4. Anon: Yohimbine hydrochloride. Mosby Inc; 1998. Available at: http://www.Rxlist.com (cited 1/6/00).
5. McGuffin M, Hobbs C, Upton R et al: Botanical Safety Handbook. CRC Press, Boca Raton, FL; 1997.
6. Lacomblez L, Bensimon G, Isnard F et al: Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine. Clin Pharmacol Ther 1989; 45(3):241-251.
7. Charney DS, Heninger GR, & Sternberg DE: Assessment of alpha-2 adrenergic autoreceptor function in humans: effect of oral yohimbine. Life Sci 1982; 30(23):2033-2041.
8. Tyler VE: Herbs of Choice: The Therapeutic use of phytomedicinals. Pharmaceutical Products Press, New York, NY; 1991.
9. Price J & Grunhaus LJ: Treatment of clomipramine-induced anorgasmia with yohimbine: a case report. J Clin Psychiatry 1990; 51(1):32-33.
10. Morales A, Surridge DH, & Marshall PG: Yohimbine for treatment of impotence in diabetes. N Engl J Med 1981; 305(20):1221.
11. Landis E & Shore E: Yohimbine-induced bronchospasm. Chest 1989; 96(6): 1424.
12. Fetrow CW & Avila JR: Professional's Handbook of Complementary and Alternative Medicines. Springhouse Corporation, Springhouse, PA; 1999:689-692.
13. Charney DS, Heninger GR & Redmond DE: Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci 1983; 33(1):19-29.
14. McDougle CJ, Krystal JH, Price LH et al: Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine. Psychopharmacology 1995; 118(2):127-135.
15. Price LH, Charney DS & Heninger GR: Three cases of manic symptoms following yohimbine administration. Am J Psychiatry 1984; 141(10):1267-1268.
16. Gear RW, Gordon NC, Heller PH et al: Enhancement of morphine analgesia by the alpha2-adrenergic antagonist yohimbine. Neuroscience 1995; 66(1):5-8.
17. Jordan J & Sharma AM: Potential for sibutramine-yohimbine interaction. Lancet 2003; 361(9371):1826.
18. Product Information: Yohimbine hydrochloride. PDR Generics, Medical Economics, MontvYohimbine hydrochloride. PDR Generics, Medical Economics, Montvale, NJ, 1997.
19. Goldberg MR & Robertson D: Yohimbine: a pharmacological probe for study of the alpha2-adrenoreceptor. Pharmacol Rev 1983; 35:143-180.
20. Goldstein DS, Grossman E, Listwak S et al: Sympathetic reactivity during a yohimbine challenge test in essential hypertension. Hypertension 1991; 18 (Suppl 3): 40-48.
21. Grossman E, Rosenthal T, Peleg E et al: Oral yohimbine increased blood pressure and sympathetic nervous outflow in hypertensive patients. J Cardiovasc Pharmacol 1993; 22:22-26.
22. Rosen MI, Kosten TR & Kreek MJ: The effects of naltrexone maintenance on the response to yohimbine in healthy volunteers. Biol Psychiatry 1999; 45(12):1636-1645.